Robotic surgery showdown: single port vs. multi port for prostate cancer
NCT ID NCT07666217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks back at the records of 625 men who had robotic prostate surgery for localized prostate cancer. It compares a newer single-port method with the standard multi-port approach to see which leads to fewer complications and better urinary control. The goal is to gather information, not to test a new drug or treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ageo Central General Hospital
Ageo, Saitama, 362-8588, Japan
-
Fujita Health University Hospital
Toyoake, Aichi-ken, 470-1192, Japan
-
Ichinomiyanishi Hospital
Ichinomiya, Aichi-ken, 494-0001, Japan
-
Kyoto City Hospital
Kyoto, Kyoto, 604-8845, Japan
-
Mie University Hospital
Tsu, Mie-ken, 514-8507, Japan
-
National Cancer Center Hospital
Tokyo, Tokyo, 104-0045, Japan
-
Saiseikai Yokohamashi Tobu Hospital
Yokohama, Kanagawa, 230-0012, Japan
-
Tokyo Medical Center
Tokyo, Tokyo, 152-8902, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?